PubMed

Surgical Artificial Intelligence Innovation Trends and Regulatory Insights: A Systematic Analysis of Food and Drug Administration-Approved Devices.

PMID: 42849513 · 2026-10-08

R, i, s, h, i, k, e, s, h, , G, a, n, d, h, e, w, a, r, ;, , A, h, m, a, d, , G, u, n, i, ;, , D, e, v, a, n, s, h, , T, a, n, d, o, n, ;, , S, o, n, a, m, , P, a, t, e, l, ;, , W, i, l, l, i, a, m, , W, a, l, d, o, c, k, ;, , N, a, f, i, , D, i, l, a, v, e, r, ;, , H, a, o, y, u, , Z, h, a, n, g, ;, , K, r, s, t, o, , P, a, n, d, z, a, ;, , A, r, a, , D, a, r, z, i, ;, , H, u, t, a, n, , A, s, h, r, a, f, i, a, n

학술지Annals of surgery

연도2026-10-08

PMID42849513

초록

To characterise the landscape of surgical artificial intelligence (AI) devices approved by the US Food and Drug Administration (FDA). AI has the potential to improve surgical pathways, offering capability across screening, diagnosis, decision support, and intraoperative care. Despite this, real-world adoption remains limited. Regulatory approval serves as a key step in clinical translation but is influenced by challenges in evidence generation, safety, bias, transparency, and implementation. Con

공식 출처

PubMed에서 보기 →

데이터는 PubMed / NCBI에서 제공됩니다. 전문과 최신 정보는 반드시 공식 기록을 확인하세요.